Development and operation of a quality assurance system for deviations from standard operating procedures in a clinical cell therapy laboratory

Cytotherapy

Volumn 5, Issue 4, 2003, Pages 314-322

  McKenna Jr , David H ^a   Kadidlo, D ^b   Sumstad, D ^b   McCullough, J ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cellular therapy; Deviation; Error; Quality assurance

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ANALYTICAL ERROR; ARTICLE; CLINICAL ARTICLE; COMPUTER SYSTEM; DATA ANALYSIS; DATA BASE; GOOD LABORATORY PRACTICE; HUMAN; LABORATORY TEST; PROCESS MONITORING; QUALITATIVE ANALYSIS; QUALITY CONTROL; SCORING SYSTEM; STANDARD; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

EID: 0142031142     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240310002234     Document Type: Article

References (11)

1. Food and Drug Administration. Guideline for quality assurance in blood establishments, Docket no. 91N-0450. Fed Reg 1995;58:35959.
2. McCullough J. Quality assurance and good manufacturing practices for processing hematopoietic progenitor cells. J Hematother 1995;4:493-01.
3. Bennett, ST, Johnson, NL, Lasky, LC. Quality assurance and standards in hematopoietic progenitor processing. J Clin Apheresis 1992;7:138-44.
4. Food and Drug Administration. Code of Fed Regulations: Title 21, Parts 210, 211, 820. Washington, DC: US Government Printing Office, 2002 (revised annually).
5. Foundation for the Accreditation of Cellular Therapy (FACT). Standards for Hematopoietic Progenitor Cell Collection, Processing and Transplantation. 2nd ed. North America; 2002.
6. American Association of Blood Banks. Standards for Hematopoietic Progenitor Cell and Cellular Product Services. 3rd ed. Bethesda, MD: American Association of Blood Banks, 2002.
7. Food and Drug Administration. Code of Federal Regulations: Title 21, Proposed 1271.3. Washington, DC: US Government Printing Office, 2001.
8. Newman-Gage H. Application of quality assurance practices in processing cells and tissue for transplantation. Cell Transplant 1995;4:447-54.
9. Rowley SD. Regulation of hematopoietic stem cell processing and transplantation. Int J Hematol 2002;75:237-45.
10. Mayhew TA, Williams GR, Senica MA et al. Validation of a quality assurance program for autologous cultured chondrocyte implantation. Tissue Eng 1998;4:325-34.
11. Duckett JB, Woods LL, Santrach PJ, editors. Quality in Action. American Association of Blood Banks, 1996.